Font Size: a A A
Keyword [programmed cell death ligand-1]
Result: 41 - 48 | Page: 3 of 3
41. The Role And Potential Mechanism Of Integrin αvβ3 Antagonist Cilengitide In Melanoma Treatment And Immune Microenvironment Regulation
42. Effect And Significance Of Radiotherapy On VEGFR2 And PD-L1 In Rectal Cancer
43. The Significance Of Lymphocyte Subsets And PD-1/PD-L1 In Ulcerative Colitis
44. Analysis Of The Impact Of EGFR Co-mutations On The Efficacy Of Immune Checkpoint Inhibitors And Immune-Related Features In Advanced Non-small Cell Lung Cancer
45. The Application Of Immune Checkpoint Inhibitors In Unresectable Hepatocellular Carcinoma:Clinical Exploration And A Meta-Analysis Of Prognosis
46. In Vitro And In Vivo Study On The Treatment Of Non-small Cell Lung Cancer With Radionuclide Labeled PD-L1 Nanobody
47. Expression Of PD-L1,CD68,CD86 And CD204 In Esophageal Squamous Cell Carcinoma Tissue And Its Clinical Significance
48. Expression And Significance Of HMGB1 And PD-L1 In Nonspecific Invasive Breast Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to